欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

全球核酸测试市场报告(2016-2020年)

Global Nucleic Acid Testing Market 2016-2020

加工时间:2017-06-16 信息来源:EMIS 索取原文[79 页]
关键词:体外诊断(IVD); 保健市场;检测;各种疾病;测试和测定
摘 要:

In-vitro diagnostics (IVD) is one of the most important segments of the global healthcare market. The tests and assays for the detection of various diseases such as cancer, tuberculosis and autoimmune diseases fall under the umbrella term of IVD market. IVD technologies has a wide range of applications in the field of clinical diagnosis. The market is dominated by the high sales of the reagents used in diagnosis, as most of the equipment are under rental or lease agreement with the enduser.


目 录:

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by product

Instruments

Reagents

PART 07: Market segmentation by indication

Market overview

Infectious diseases

Cancer

Genetics

PART 08: Market segmentation by technology

Polymerase chain reaction (PCR)

Strand displacement amplification (SDA)

Ligase chain reaction (LCR)

Others

PART 09: Market segmentation by end-users

Hospitals

Clinics

Research institutes

PART 10: Geographical segmentation

Nucleic acid testing market in Americas

Nucleic acid testing market in the EMEA

Nucleic acid testing market in the APAC

PART 11: Market drivers

Genome engineering and gene editing on rise

Higher adoption rate of molecular point-of-care (POC)

testing

Improved sensitivity for the detection systems

PART 12: Impact of drivers

PART 13: Market challenges

High cost of equipment and reagents

Stringent regulatory framework

Risks associated with molecular diagnosis

PART 14: Impact of drivers and challenges

PART 15: Market trends

Next generation sequencing

Higher adoption rate for NAT

Advances in precision and personalized medicine

PART 16: Vendor landscape

Competitive scenario

PART 17: Key vendor analysis

Abbott Laboratories

Roche Molecular Systems

Siemens Healthineers

Hologic

Qiagen

Key Companies to watch

Other prominent vendors

PART 18: Appendix

List of abbreviations

PART 19: Explore Technavio 


© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服